Dr. Shabahang is a co-founder and President of SEKRIS Biomedical, Inc. He received his DDS in 1987 from University of Pacific, specialty training and MS in 1997 from Loma Linda University, and a PhD in Microbiology and Molecular Genetics from Loma Linda University in 2001. During his tenure as a member of the faculty at Loma Linda University, he maintained a laboratory with research emphasis on the effects of local infections on systemic diseases

Dr. Alan Escher received his BSc magna cum laude from the University of Connecticut and PhD from Cornell University. Dr. Escher is co-founder of SEKRIS and heading its R&D program. He was previously Associate Professor and Associate Director of the Center for Transplant Immunology Research at the Loma Linda University School of Medicine, where Dr. Escher and colleagues started to develop pro-apoptotic DNA vaccination for the treatment of type 1 d

Dr. Joachim-Friedrich Kapp joined Schering AG, Germany, in 1975 as a scientist in the Department of Inflammation Research and Immunology. He became Section Head in 1976 and Department Head in 1977. In 1980 he transferred as Medical Director to Schering’s newly acquired US subsidiary, Berlex, and was appointed Vice President and Head of Research and Development in 1981. From 1984 through 1990 he was with Warner-Lambert’s German subsidiary Goedecke

Dr. Neil P. Desai PhD serves as Vice President, Strategic Platforms at Celgene Corp. Dr. Desai has more than 20 years of experience in the research and development of novel therapeutics, drug delivery systems and biocompatible polymers. Until October 2010, he served as Senior Vice President, Global Research and Development at Abraxis BioScience, Inc. (ABI) where he was responsible for the development of ABI's proprietary product pipeline and inte

Charles Crocker is Chairman and CEO of Crocker Capital, a private venture capital firm. Mr. Crocker served as Chairman of the Board and CEO of BEI Technologies, Inc., a NASDAQ listed, diversified technology company, which he founded. BEI was sold to Schneider Electric, a global French conglomerate, in October, 2005. Mr. Crocker was also Chairman, CEO, and founder of BEI Medical Systems, a public medical device company, sold to Boston Scientifi